<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="are approved to treat other DNA virus infections, most frequently" exact="cidofovir" post="(CDV). CDV, however, has considerable nephrotoxicity, thus it is"/>
 <result pre="by virus replication to a larger extent. We show that" exact="valganciclovir" post="(VGCV), a drug that was shown to be active"/>
 <result pre="most serious cases [14]. Ribavirin and to a lesser extent" exact="ganciclovir" post="(GCV) have also been used (for reviews, see [3,5,6,7,8,9,10,11,15,16])."/>
 <result pre="Ad infection in immunocompromised patients, the animals are immunosuppressed by" exact="cyclophosphamide" post="[24] and then are infected intravenously (i.v.) with Ad5."/>
 <result pre="even reversed with the use of BCV [24,27], GCV [26]," exact="valganciclovir" post="(VGCV) [25], or CDV [27]. Previously, we have shown"/>
 <result pre="Infection of Hamsters with Adenovirus The animals were immunosuppressed using" exact="cyclophosphamide" post="(CP) as described before [24]. CP was administered intraperitoneally"/>
 <result pre="with human type 5 adenovirus in immunosuppressed syrian hamsters, while" exact="ribavirin" post="is largely ineffective in this modelAntivir. Res.2014112384610.1016/j.antiviral.2014.10.00525453340 28.ThomasM.A.SpencerJ.F.La ReginaM.C.DharD.TollefsonA.E.TothK.WoldW.S.Syrian"/>
 <result pre="adenovirus replication in immunocompetent syrian hamsters can be attenuated with" exact="chlorpromazine" post="or cidofovirJ. Gene Med.20101243544510.1002/jgm.145320440754 36.SoldinO.P.MattisonD.R.Sex differences in pharmacokinetics and"/>
</results>
